×
About 1,383 results

ALLMedicine™ Hypersensitivity Pneumonitis Center

Research & Reviews  484 results

Integration and application of clinical practice guidelines for the diagnosis of idiopa...
https://doi.org/10.1016/j.chest.2022.06.013
Chest Marinescu DC, Raghu G et. al.

Jun 24th, 2022 - Recent clinical practice guidelines have addressed the diagnosis of idiopathic pulmonary fibrosis (IPF) and fibrotic hypersensitivity pneumonitis (fHP). These disease-specific guidelines were developed independently, without clear direction on how...

Clinical radiological and pathological staging of children with hypersensitivity pneumo...
https://doi.org/10.1002/ppul.26038
Pediatric Pulmonology; Ozsezen B, Özcan HN et. al.

Jun 10th, 2022 - Hypersensitivity pneumonitis (HP) is rare in the pediatric population. To date, there are no studies defining a correlation between clinical, radiological, and pathological findings in children with HP. The objective of this study is to define the...

Idiopathic Pulmonary Fibrosis Update. Reconciliation with Hypersensitivity Pneumonitis ...
https://doi.org/10.1164/rccm.202205-0989LE
American Journal of Respiratory and Critical Care Medicine; Moran-Mendoza O

Jun 8th, 2022 - Idiopathic Pulmonary Fibrosis Update. Reconciliation with Hypersensitivity Pneumonitis Guidelines Required?|2022|Moran-Mendoza O,|

Reply to: Idiopathic Pulmonary Fibrosis Update. Reconciliation with Hypersensitivity Pn...
https://doi.org/10.1164/rccm.202206-1058LE
American Journal of Respiratory and Critical Care Medicine; Raghu G, Richeldi L et. al.

Jun 8th, 2022 - Reply to: Idiopathic Pulmonary Fibrosis Update. Reconciliation with Hypersensitivity Pneumonitis Guidelines Required?|2022|Raghu G,Richeldi L,Thomson CC,Remy-Jardin M,Wilson KC,|

see more →

Guidelines  3 results

Executive Summary: Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guid...
https://doi.org/10.1016/j.chest.2021.03.067
Chest Fernández Pérez ER, Travis WD et. al.

Apr 19th, 2021 - The purpose of this summary is to provide a synopsis of evidence-based and consensus-derived guidance for clinicians to improve individual diagnostic decision-making for hypersensitivity pneumonitis (HP) and decrease diagnostic practice variabilit...

Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Pa...
https://doi.org/10.1016/j.chest.2021.03.066
Chest Fernández Pérez ER, Travis WD et. al.

Apr 17th, 2021 - The purpose of this analysis is to provide evidence-based and consensus-derived guidance for clinicians to improve individual diagnostic decision-making for hypersensitivity pneumonitis (HP) and decrease diagnostic practice variability. Approved p...

Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397797
American Journal of Respiratory and Critical Care Medicine; Raghu G, Remy-Jardin M et. al.

Jul 25th, 2020 - Background: This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It represents a collaborative effort among the American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana del Tórax.Methods: Syst...

see more →

Drugs  11 results see all →

Clinicaltrials.gov  21 results

Immune Response in Hypersensitivity Pneumonitis
https://clinicaltrials.gov/ct2/show/NCT03873649

May 18th, 2022 - Hypersensitivity pneumonitis (HP) is a granulomatous lung disorder triggered by exposure to one of a multitude of organic antigens. Incidence rates of HP vary by geography, season and population studied but it is estimated to be the third most com...

HypErsensitiVity PneumonITis: DiseAse Progression Characterization
https://clinicaltrials.gov/ct2/show/NCT04961944

Apr 21st, 2022 - EVITA is a multicentric Latin-American prospective cohort on chronic hypersensitivity pneumonitis. EVITA's objective is to identify phenotypes and/or endotypes associated with different disease trajectories measured primarily by forced vital capac...

129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study
https://clinicaltrials.gov/ct2/show/NCT04677426

Apr 14th, 2022 - This research is a study to test the reliability of Hyperpolarized Xenon MRI (HXe MRI) as a biomarker in interstitial lung disease. The study is a non-randomized study to evaluate the test-retest performance of HXe MRI in Idiopathic Pulmonary Fibr...

A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis
https://clinicaltrials.gov/ct2/show/NCT04844359

Apr 12th, 2022 - Hypersensitivity pneumonitis is an immunologically mediated form of lung disease, resulting from inhalation exposure to a large variety of antigens. For unknown reasons, a subgroup of patients with HP without a known inciting antigen exposure deve...

Assessing Health Related Quality of Life in Hypersensitivity Pneumonitis
https://clinicaltrials.gov/ct2/show/NCT04273867

Jan 27th, 2022 - The objective of this study is to administer and validate a disease-specific health related quality of life (HRQOL) survey for patients with Chronic Hypersensitivity Pneumonitis (CHP). The survey items have been developed and revised from prior qu...

see more →

News  34 results

Cough-Specific QOL Linked to Poor Outcomes in ILD Patients
https://www.medscape.com/viewarticle/972378

Apr 19th, 2022 - Poor cough-specific quality of life (QOL) was independently associated with respiratory hospitalization, death, and lung transplantation in a large population of well-characterized patients with interstitial lung disease (ILD), new research shows....

Fast Five Quiz: Progressive Fibrosing Interstitial Lung Disease
https://www.medscape.com/viewarticle/969959

Apr 12th, 2022 - Interstitial lung diseases (ILDs) encompass a large and varied group of parenchymal lung disorders, including diseases of unknown cause, which are known as idiopathic interstitial pneumonias, as well as those associated with other diseases or envi...

Update – CHEST clinical practice guidelines
https://www.mdedge.com/chestphysician/article/244646/society-news/update-chest-clinical-practice-guidelines
Jonathan M. Iaccarino, MD, MS

Sep 13th, 2021 - CHEST has a long history of developing high quality clinical practice guidelines based on rigorous methodology, particularly in Thoracic Oncology, Pulmonary Vascular/Venous Thromboembolic Disease, and Clinical Pulmonary Medicine/Cough. Using the G.

Bronchiolitis: Rare diseases, diagnostic challenges, and few proven therapies
https://www.mdedge.com/chestphysician/article/234987/pulmonology/bronchiolitis-rare-diseases-diagnostic-challenges-and-few
Brian R. Poole, MD, Sean J. Callahan, MD

Feb 11th, 2021 - What’s in a name? Bronchiolitis, a group of diseases also referred to as “small airways diseases,” is characterized by inflammation and/or fibrosis in airways less than 2 mm in diameter. In pediatric patients, it is most commonly related to acute.

Overview and Management of Drug-Induced Interstitial Lung Disease With Novel Treatments in HER2+ Breast Cancer, Lung Cancers, and Gastrointestinal Cancers
https://www.onclive.com/view/overview-and-management-of-drug-induced-interstitial-lung-disease-with-novel-treatments-in-her2

Aug 24th, 2020 - Recently developed treatments for human epidermal growth factor receptor 2 (HER2)-positive (HER2+) breast cancer, lung cancers, and gastrointestinal (GI) cancers include antibody-drug conjugates (ADCs), cyclin-dependent kinase (CDK) 4/6 inhibitors...

see more →